ArticleAJNR. American journal of neuroradiology2026
Perfusion-Based Collaterals in Prediction of Infarct Growth in Patients with Acute Ischemic Stroke: A Multicenter Comparative Analysis.
Article in AJNR. American journal of neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background and purposeIn patients with acute ischemic stroke (AIS), robust collaterals are associated with lower rates of infarct growth. Perfusion-based collateral matrices, including hypoperfusion intensity ratio (HIR), relative CBV (rCBV) index, and perfusion collateral index (PCI), have been used successfully to assess collaterals in patients with AIS. We aimed to assess and compare the diagnostic ability of these perfusion-based collateral indices in the prediction of infarct growth in patients with AIS after successful reperfusion. MATERIALS AND
methodsIn this retrospective multicenter study, patients with anterior circulation large vessel occlusion were included if they had pretreatment perfusion (CT or MR), successful reperfusion (modified TICI ≥ 2b), and follow-up MRI within 24-48 hours from the date of treatment. The primary outcome assessed was substantial infarct growth, which was defined as a final infarct volume of ≥10 mL compared with the baseline ischemic core volume. Perfusion-based collateral indices including HIR (volume of time-to-maximum [Tmax] >10 seconds/volume of Tmax >6 seconds) and rCBV index (mean of rCBV values within the volume of Tmax > 6 seconds) were calculated using RAPID software (Version 5.0.4), and PCI (volume of delay
resultsAmong 116 included patients, 58 (50%) had infarct growth ≥10 mL. Infarct growth volume (median, interquartile range) was: 11, 2.6-34.7 mL. Poor collaterals determined by PCI and rCBV index was significantly (
conclusionsPerfusion-based collateral indices that integrate CBV (rCBV index and PCI) outperformed delay-based HIR in the prediction of substantial infarct growth in patients with AIS, and may play an important role in treatment decision-making, patient transfer decisions, and prognostication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.